Sodium-Glucose Cotransporter-2 Inhibitors for Hyperglycemia in Phosphoinositide 3-kinase Pathway Inhibition

PURPOSE: Phosphoinositide 3-kinase (PI3K) inhibition is used for the treatment of certain cancers, but can cause profound hyperglycemia and insulin resistance, for which sodium-glucose cotransporter-2 (SGLT2) inhibitors have been proposed as a preferred therapy. The objective of this research is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Weintraub, Michael A, Liu, Dazhi, DeMatteo, Raymond, Goncalves, Marcus DaSilva, Flory, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055504/
https://www.ncbi.nlm.nih.gov/pubmed/36993733
http://dx.doi.org/10.21203/rs.3.rs-2655905/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055504/
https://www.ncbi.nlm.nih.gov/pubmed/36993733
http://dx.doi.org/10.21203/rs.3.rs-2655905/v1

Ejemplares similares